Project Grant R42HL134455

The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $1,024,635 project grant to Corvion, Inc. to develop a Totally Implanted Left Ventricular Assist Device (TI-LVAD). The TI-LVAD aims to reduce complications and enhance quality of life for heart failure patients by eliminating the need for a percutaneous driveline and external power supply. The key innovation is a hybrid magnetically levitated blood pump that requires...

Federal Project Grant Award Summary Perfusion Solutions Inc. received $320,838 in funding under the National Heart, Lung, and Blood Institute's (NHLBI) Cardiovascular Diseases Research program (CFDA 93.837) for the development of a fail-safe, high-output mechanical circulatory support device. The award, issued on September 5, 2025, and concluding February 28, 2027, addresses NHLBI Topic of Special Interest HLS17-15 for developing mechanical circulatory support devices for individuals with single...

This $274,995 National Science Foundation Technology, Innovation, and Partnerships program Project Grant will support the development of a semi-active magnetic bearing for flywheel energy storage systems by Magma Space LLC. The magnetic bearing technology aims to enable high-speed flywheel energy storage systems for both space and terrestrial applications by overcoming limitations of lithium-ion batteries such as loss of energy capacity over time and stringent temperature control requirements....

This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...

This $7,836,599.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the development of a novel centrifugal left ventricular assist device (LVAD) with wireless power transfer and anti-thrombotic coating technology. The prime awardee, Georgia Tech Research Corporation, will lead the research and development efforts, which include fabricating and characterizing slippery hydrophilic (SLIC) coatings to improve...

This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $550,000 to develop electric motors that use electromagnetic forces to eliminate bearings. The project aims to transform the reliability, lifetime, efficiency, and utility of electric motors and generators across industries like transportation, manufacturing, and medical equipment. By creating a cost-effective solution that uses...

This $437,461 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a novel stabilization catheter device for His pacing lead implantation. The goal is to improve the accuracy and ease of His bundle pacing, an emerging alternative cardiac resynchronization therapy (CRT) for heart failure patients. The project aims to refine a deployable suction-tipped lead...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant award of $275,000 to Adialante L.L.C. focuses on the development of techniques to facilitate the design and fabrication of affordable, compact, and patient-friendly magnetic resonance imaging (MRI) systems, particularly for pediatric applications. The project aims to innovate novel B1 imaging approaches, such as Frequency-Encoded and Phase-Encoded Frequency-Modulated Rabi-Encoded Echoes (FREE), that...

This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...

Federal Project Grant Award Summary Heartpoint Global Inc. received a $1.77 million project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2027. The award funds the development of INTELLISTENT, a minimally invasive, adjustable pulmonary flow restrictor system designed to treat congenital and acquired heart disease in pediatric patients. The project addresses a...